Market Place
Sourcing Support
Sorrento Announces Positive Phase IIa Study Results of Abivertinib
05 Jul 2023 //
GLOBENEWSWIRE
Sorrento Announces Trial Results as Assessed by an IRC of Abivertinib
23 Aug 2022 //
GLOBENEWSWIRE
FDA Clears Sorrento`s Phase 2/3 Study for Abivertinib in Severe Pneumonia
31 Mar 2022 //
GLOBENEWSWIRE
Sorrento Announces Encouraging Results From Two Phase 2 Studies
27 Oct 2021 //
GLOBENEWSWIRE
Sorrento Announces Encouraging Results From Two Ph2 Studies of Abivertinib
27 Oct 2021 //
GLOBENEWSWIRE
Sorrento Announces Phase 2 Abivertinib Studies Have Completed Patient Enrollment
22 Jun 2021 //
GLOBENEWSWIRE
FDA clears Abivertinib for Ph2 safety and efficacy study
20 Jul 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.